Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
44.43
-0.31 (-0.69%)
At close: May 22, 2026, 4:00 PM EDT
44.09
-0.34 (-0.77%)
After-hours: May 22, 2026, 7:46 PM EDT
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $4.13 billion as of May 22, 2026. Its market cap has increased by 127.62% in one year.
Market Cap
4.13B
Enterprise Value
4.19B
1-Year Change
127.62%
Ranking
Category
Stock Price
$44.43
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $4.13B, an increase of 10,126.92%. That is a compound annual growth rate of 41.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 4.13B | 20.86% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.73B |
| Ligand Pharmaceuticals | 4.60B |
| Caris Life Sciences | 4.40B |
| Veradermics | 4.25B |
| NewAmsterdam Pharma Company | 4.14B |
| Crinetics Pharmaceuticals | 3.88B |
| Catalyst Pharmaceuticals | 3.83B |
| Oruka Therapeutics | 3.66B |